or
Bookmark and Share
5-Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
   
Document Number
US Patent 4426388
Issued Date
January 17, 1984
Link
Inventors
Map
Abstract
Novel carboxylic acid esters of 5-hydroxy-2-benzothiazolesulfonamide are shown to be useful for the topical treatment of elevated intraocular pressure. Ophthalmic compositions including drops and inserts are also disclosed, as well as methods for preparing the novel compounds.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
14
Comments:
no comments yet
Owner
Merck & Co., Inc. (Rahway, NJ)
[*] Notice:The portion of the term of this patent subsequent to November 22, 2000 has been disclaimed.
Published
January 17, 1984
Application Number
06/364,953
Filed
April 2, 1982
US Classification
514/367   514/913 548/166
Int'l Classification
C07D   277/00   (20060101)   C07D   277/80   (20060101)  
Examiner
USPTO Field of Search
548/166   424/270  
Related Patents
4456599 - Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure - Owned by Merck & Co., Inc. (Rahway, NJ)

Novel phosphates of 6(or 5)-hydroxy-2-benzothiazolesulfonamide are useful for the topical treatment of elevated intraocular pressure. Ophthalmic compositions include drops and inserts.

4544667 - 2-Sulfamoylbenzo[b]furan derivatives for the treatment of elevated intraocular pressure - Owned by Merck & Co., Inc. (Rahway, NJ)

Novel 2-sulfamoylbenzo[b]furans and derivatives thereof are shown to be useful for the treatment of elevated intraocular pressure in compositions including opthalmic drops and inserts.

4929637 - Substituted thiophene-2-sulfonamide antiglaucoma agents - Owned by Merck & Co., Inc. (Rahway, NJ) [*] Notice:The portion of the term of this patent subsequent to January 26, 2005 has been disclaimed.

Thiophene-2-sulfonamides with an alkyl or substituted-alkyl and an alkyl-S(O).sub.n -substituent are carbonic anhydrase inhibitors useful in the treatment of elevated intraocular pressure.

5789435 - Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight - Owned by Advanced Research and Technology Institute (Bloomington, IN)

There is disclosed a method for increasing retinal and optic nerve head blood velocity by topical application of carbonic anhydrase inhibitors to the eye.

5091409 - 4-alkylamino-6-(C.sub.3-5 -hydrocarbyl)thieno[2,3-B]thiopyran-2-sulfonamide-7,7-dioxides - Owned by Merck & Co., Inc. (Rahway, NJ)

4-Alkylamino-6-(C.sub.3-5 -hydrocarbyl)thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxides wherein the 4-alkylamino group is an ethylamino or propylamino are powerful carbonic anhydrase inhibitors useful in the treatment of ocular hypertension and glaucoma associated therewith. These compounds have the formula ##STR1##

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us